Physician profile
Michael Ferrick
NPI 1144762592
$5,563.97
in general payments reported to CMS, 2019-2025
10 companies · $2,479 in 2025
The $2,479 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $427 · 2022: $775 · 2023: $1,525 · 2024: $358 · 2025: $2,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,138 · Food and Beverage: $1,499 · Travel and Lodging: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,137.50 |
| Food and Beverage | $1,499.29 |
| Travel and Lodging | $724.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $2,316.84 | 2025 | |
| Medtronic, INC. | $1,388.78 | 2021-2023 | Synchromedii, Intellis Adaptivestim |
| Mml US, INC. | $875.53 | 2022-2025 | Reactiv8 |
| Boston Scientific Corporation | $484.21 | 2021-2022 | |
| Abbott Laboratories | $236.34 | 2021-2024 | Proclaim |
| Biotronik Nro, INC. | $147.07 | 2024 | Prospera |
| Abbvie INC. | $39.68 | 2025 | |
| Lundbeck LLC | $33.79 | 2023 | Vyepti |
| Nalu Medical, INC. | $25.97 | 2025 | Nalu Neurostimulation System |
| Nevro Corp. | $15.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ferrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.